关注
Kevin Cowart
Kevin Cowart
在 usf.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Systematic review of randomized controlled trials evaluating glycemic efficacy and patient satisfaction of intermittent-scanned continuous glucose monitoring in patients with …
K Cowart, W Updike, K Bullers
Diabetes Technology & Therapeutics 22 (5), 337-345, 2020
302020
Oral semaglutide: first-in-class oral GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
K Cowart
Annals of Pharmacotherapy 54 (5), 478-485, 2020
302020
Evaluation of FDA boxed warning on prescribing patterns of fluoroquinolones for uncomplicated urinary tract infections
K Cowart, M Worley, NE Rouby, K Sando
Annals of Pharmacotherapy 53 (12), 1192-1199, 2019
282019
Overbasalization: addressing hesitancy in treatment intensification beyond basal insulin
K Cowart
Clinical Diabetes 38 (3), 304-310, 2020
272020
An examination of correlations between MMI scores and pharmacy school GPA
K Cowart, K Dell, N Rodriguez-Snapp, HMW Petrelli
American Journal of Pharmaceutical Education 80 (6), 2016
252016
Impact of pharmacist care provision in value-based care settings: How are we measuring value-added services?
K Cowart, K Olson
Journal of the American Pharmacists Association 59 (1), 125-128, 2019
192019
Pharmacist Impact on Treatment Intensification and Hemoglobin A1C in Patients With Type 2 Diabetes Mellitus at an Academic Health Center
K Cowart, K Sando
Journal of Pharmacy Practice 32 (6), 648-654, 2019
172019
Protecting the integrity of the virtual objective structured clinical examination
WH Updike, K Cowart, JL Woodyard, E Serag-Bolos, JR Taylor, SD Curtis
American journal of pharmaceutical education 85 (6), 2021
162021
Continuous glucose monitoring in persons with type 2 diabetes not using insulin
K Cowart, WH Updike, R Franks
Expert Review of Medical Devices 18 (11), 1049-1055, 2021
132021
Pharmacy student perception of a remote hypertension and drug information simulation‐based learning experience in response to the SARS‐CoV‐2 pandemic
K Cowart, WH Updike
Journal of the American College of Clinical Pharmacy 4 (1), 53-59, 2021
112021
Using an Advanced Practice Pharmacist in a Team-Based Care Model to Decrease Time to Hemoglobin A1c Goal Among Patients With Type 2 Diabetes, Florida …
K Cowart, W Updike, N Emechebe, J Zgibor
Preventing Chronic Disease 17, E40, 2020
92020
Prevalence of and characteristics associated with overbasalization among patients with type 2 diabetes using basal insulin: a cross-sectional study
K Cowart, WH Updike, R Pathak
Clinical Diabetes 39 (2), 173-175, 2021
82021
Evaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial?
K Cowart, NW Carris
Expert Opinion on Pharmacotherapy 22 (2), 163-165, 2021
82021
Change in proportion of days covered for statins following implementation of a pharmacy student adherence outreach program
C Tamargo, K Sando, Y Prados, K Cowart
Journal of managed care & specialty pharmacy 25 (5), 588-592, 2019
82019
Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss
N Durell, R Franks, S Coon, K Cowart, NW Carris
Journal of Pharmacy Technology 38 (5), 283-288, 2022
72022
A review of the first long-term implantable continuous glucose monitoring system available in the United States
K Cowart
Journal of Diabetes Science and Technology 15 (1), 160-166, 2021
72021
Measurement of pharmacist-physician collaborative care on therapeutic inertia in patients with type 2 diabetes
K Cowart, N Emechebe, R Pathak, L Abbruzese, J Hann, A Lloyd, ...
Annals of Pharmacotherapy 56 (2), 155-161, 2022
62022
Undetectable Vancomycin Concentrations Utilizing a Particle Enhanced Turbidimetric Inhibition Immunoassay in a Patient with an Elevated IgM Level.
AA Cooper, K Cowart, A Clayton, J Paul
Clinical Laboratory 63 (9), 1527-1532, 2017
62017
Pharmacist-Driven Continuous Glucose Monitoring in Community and Ambulatory Care Pharmacy Practice: A Scoping Review
A Vascimini, Y Saba, F Baskharoun, K Crooks, V Huynh, S Wasson, ...
Journal of the American Pharmacists Association, 2023
52023
Inclisiran for the Treatment of Hyperlipidemia and for Atherosclerotic Cardiovascular Disease Risk Reduction: A Narrative Review
K Cowart, J Singleton, NW Carris
Clinical Therapeutics, 2023
42023
系统目前无法执行此操作,请稍后再试。
文章 1–20